Trending News
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- Risankizumab (Skyrizi®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn’s Disease
- Managing Postoperative Crohn’s Disease Made Easy
- Dispatches from the GUILD Conference 2021
- Teduglutide and Short Bowel Syndrome in Children
- How Common are Pediatric Feeding Disorders?
- This event has passed.
ObesityWeek 2019
November 3, 2019 - November 9, 2019
ObesityWeek is the seventh annual scientific and educational obesity-centric conference in the world with the broadest, most comprehensive bench-to-bedside and continuum of care content.
At ObesityWeek world-renowned experts will explore leading-edge science, clinical interventions, and policy approaches to combat the obesity epidemic.
ObesityWeek is organized by The Obesity Society (TOS) and the American Society for Metabolic and Bariatric Surgery (ASMBS).
~ 4000 participants
30.25 AMA PRA Category 1 Credits™ – maximum
30.25 ABS MOC points
30.25 CNE contact hours